“Indacaterol/ Glycopyrronium in Symptomatic Patients with COPD (GOLD 2 and GOLD 3) Versus Salmeterol/ Fluticasone” (2025) Indus Journal of Bioscience Research, 3(4), pp. 614–617. doi:10.70749/ijbr.v3i4.859.